Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for October 29th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 29th:

ConnectOne Bancorp, Inc. (CNOB - Free Report) : This bank holding company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.2% over the last 60 days.

ConnectOne Bancorp’s shares gained 10.5% over the last one month above the S&P 500’s increase 2.1%. The company possesses a Momentum Score of A.

Frontline Ltd. (FRO - Free Report) : This shipping company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Frontline’s shares gained 13.7% over the last one month. The company possesses a Momentum Score of A.

HOYA Corporation (HOCPY - Free Report) : This life care and information technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 3.3% over the last 60 days.

Hoya Corp. Price and Consensus

Hoya Corp. Price and Consensus

Hoya Corp. price-consensus-chart | Hoya Corp. Quote

HOYA Corporation’s shares gained 2.8% over the last one month. The company possesses a Momentum Score of A.

M/I Homes, Inc. (MHO - Free Report) : This builder of single-family homes has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.

M/I Homes’ shares gained 16.7% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in